| abstract |
The present invention relates to pharmaceutical aqueous suspension formulations for parenteral administration wherein pH is substantially stabilized, comprising a biologically active compound and a pH-controlling effective concentration of L-methionine. Preferably, the biologically active compound is a steroid compound, such as exemestane, methoxyprogesterone acetate, estradiol cypionate or a mixture of methoxyprogesterone acetate and estradiol cypionate. |